Search

everythinglearnresearchcommunity

for

Search:↓

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

N-acetylcysteine may help treat uterine and placental issues in PCOS.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Nanomaterials could improve PCOS treatment by delivering drugs more effectively with fewer side effects.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

5α-Reductase inhibitors, like finasteride, can cause serious, persistent side effects not always listed in official drug information.

Women with PCOS have a higher risk of heart disease.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Biotin can interfere with lab tests, causing misdiagnosis.

Proper nutrition can help manage PCOS symptoms and improve overall health.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Different PCOS subgroups have similar metabolic features, but those without menstrual problems have milder issues.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

VHL disease can cause early paragangliomas, needing lifelong monitoring.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.